South Korea · Delayed Price · Currency is KRW Bioneer Statistics
Total Valuation
Bioneer has a market cap or net worth of KRW 262.23 billion. The enterprise value is 293.43 billion.
| Market Cap | 262.23B |
| Enterprise Value | 293.43B |
Important Dates
The last earnings date was Wednesday, April 1, 2026.
| Earnings Date | Apr 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bioneer has 25.81 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 25.81M |
| Shares Outstanding | 25.81M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 18.61% |
| Owned by Institutions (%) | 4.17% |
| Float | 20.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.79 |
| PB Ratio | 1.16 |
| P/TBV Ratio | 1.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 25.38 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.13, with an EV/FCF ratio of -7.79.
| EV / Earnings | -104.31 |
| EV / Sales | 0.89 |
| EV / EBITDA | 12.13 |
| EV / EBIT | 19.27 |
| EV / FCF | -7.79 |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.47.
| Current Ratio | 2.25 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 4.40 |
| Debt / FCF | -2.82 |
| Interest Coverage | 3.30 |
Financial Efficiency
Return on equity (ROE) is 0.75% and return on invested capital (ROIC) is 1.11%.
| Return on Equity (ROE) | 0.75% |
| Return on Assets (ROA) | 2.71% |
| Return on Invested Capital (ROIC) | 1.11% |
| Return on Capital Employed (ROCE) | 5.01% |
| Weighted Average Cost of Capital (WACC) | 4.12% |
| Revenue Per Employee | 899.48M |
| Profits Per Employee | -7.67M |
| Employee Count | 367 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 1.95 |
Taxes
In the past 12 months, Bioneer has paid 8.20 billion in taxes.
| Income Tax | 8.20B |
| Effective Tax Rate | 82.76% |
Stock Price Statistics
The stock price has decreased by -27.50% in the last 52 weeks. The beta is 0.22, so Bioneer's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -27.50% |
| 50-Day Moving Average | 12,154.00 |
| 200-Day Moving Average | 13,561.40 |
| Relative Strength Index (RSI) | 39.95 |
| Average Volume (20 Days) | 71,575 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioneer had revenue of KRW 330.11 billion and -2.81 billion in losses. Loss per share was -109.00.
| Revenue | 330.11B |
| Gross Profit | 256.79B |
| Operating Income | 15.23B |
| Pretax Income | 9.90B |
| Net Income | -2.81B |
| EBITDA | 24.19B |
| EBIT | 15.23B |
| Loss Per Share | -109.00 |
Balance Sheet
The company has 92.51 billion in cash and 106.41 billion in debt, with a net cash position of -13.90 billion or -538.47 per share.
| Cash & Cash Equivalents | 92.51B |
| Total Debt | 106.41B |
| Net Cash | -13.90B |
| Net Cash Per Share | -538.47 |
| Equity (Book Value) | 226.99B |
| Book Value Per Share | 8,125.95 |
| Working Capital | 82.75B |
Cash Flow
In the last 12 months, operating cash flow was 10.33 billion and capital expenditures -48.01 billion, giving a free cash flow of -37.68 billion.
| Operating Cash Flow | 10.33B |
| Capital Expenditures | -48.01B |
| Depreciation & Amortization | 8.97B |
| Net Borrowing | 32.58B |
| Free Cash Flow | -37.68B |
| FCF Per Share | -1,459.85 |
Margins
Gross margin is 77.79%, with operating and profit margins of 4.61% and -0.85%.
| Gross Margin | 77.79% |
| Operating Margin | 4.61% |
| Pretax Margin | 3.00% |
| Profit Margin | -0.85% |
| EBITDA Margin | 7.33% |
| EBIT Margin | 4.61% |
| FCF Margin | n/a |
Dividends & Yields
Bioneer does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.05% |
| Shareholder Yield | -0.05% |
| Earnings Yield | -1.07% |
| FCF Yield | -14.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bioneer has an Altman Z-Score of 2.74 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.74 |
| Piotroski F-Score | 5 |